StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
VREO

Vireo Growth Inc.

VREOF OTC Pharmaceutical Preparations EDGAR ↗
$9.65
+0.28 +2.99%

Key statistics

from XBRL data in SEC filings
Market cap
$10.4B
Revenue (TTM)
$350M
Net income (TTM)
-$81.9M
EPS (TTM)
$-0.09
P/E ratio
Dividend yield
Free cash flow
-$24.6M
Cash
$138M
Total assets
$929M
Gross margin
49.6%
52-week range
$8.91 – $24.00

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Entered a material agreement Jul 30, 2026 8-K Other events Jul 27, 2026 8-K Entered a material agreement; Regulation FD disclosure Jul 23, 2026 8-K/A Jun 18, 2026 8-K Entered a material agreement; Regulation FD disclosure Jun 18, 2026 8-K/A Jun 11, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure Jun 11, 2026 8-K Regulation FD disclosure; Other events Jun 11, 2026 8-K Changed accountants; Regulation FD disclosure Jun 9, 2026 8-K Shareholder vote results Jun 3, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure May 29, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release) May 12, 2026 8-K Entered a material agreement; Regulation FD disclosure May 5, 2026 8-K Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity; Regulation FD disclosure Apr 14, 2026 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Director or officer change; Regulation FD disclosure; Other events Apr 6, 2026 8-K Regulation FD disclosure; Other events Mar 30, 2026 8-K Entered a material agreement; Completed an acquisition or disposition; Took on a direct financial obligation; Regulation FD disclosure Mar 25, 2026 10-K Fiscal year ended 2025-12-31 Mar 17, 2026 8-K Results of operations (earnings release) Mar 17, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Dec 30, 2025 8-K Unregistered sale of equity; Regulation FD disclosure; Other events Dec 29, 2025 8-K Entered a material agreement; Regulation FD disclosure Dec 22, 2025 8-K Other events Dec 10, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Regulation FD disclosure; Other events Nov 3, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Regulation FD disclosure Oct 14, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Oct 8, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Results of operations (earnings release) Aug 13, 2025 8-K/A Aug 8, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Director or officer change; Regulation FD disclosure Jul 11, 2025 8-K Shareholder vote results Jun 23, 2025 8-K Regulation FD disclosure Jun 17, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure Jun 12, 2025 8-K/A Took on a direct financial obligation Jun 12, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Delisting notice or listing-rule failure; Regulation FD disclosure Jun 6, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Delisting notice or listing-rule failure; Director or officer change; Regulation FD disclosure May 12, 2025 10-Q Quarter ended 2025-03-31 May 9, 2025